Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1990 1
1991 2
1992 1
1999 2
2001 2
2004 3
2005 1
2006 2
2007 2
2008 2
2012 1
2013 1
2015 1
2017 2
2018 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for gigler g[au]
Your search for Gigley G[au] retrieved no results
A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
Ling I, Mihalik B, Etherington LA, Kapus G, Pálvölgyi A, Gigler G, Kertész S, Gaál A, Pallagi K, Kiricsi P, Szabó É, Szénási G, Papp L, Hársing LG, Lévay G, Spedding M, Lambert JJ, Belelli D, Barkóczy J, Volk B, Simig G, Gacsályi I, Antoni FA. Ling I, et al. Among authors: gigler g. Eur J Pharmacol. 2015 Oct 5;764:497-507. doi: 10.1016/j.ejphar.2015.07.005. Epub 2015 Jul 11. Eur J Pharmacol. 2015. PMID: 26169564
Loop F of the GABAA receptor alpha subunit governs GABA potency.
Pálvölgyi A, Móricz K, Pataki Á, Mihalik B, Gigler G, Megyeri K, Udvari S, Gacsályi I, Antoni FA. Pálvölgyi A, et al. Among authors: gigler g. Neuropharmacology. 2018 Jan;128:408-415. doi: 10.1016/j.neuropharm.2017.10.042. Epub 2017 Nov 3. Neuropharmacology. 2018. PMID: 29109059
Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
Gacsályi I, Nagy K, Pallagi K, Lévay G, Hársing LG Jr, Móricz K, Kertész S, Varga P, Haller J, Gigler G, Szénási G, Barkóczy J, Bíró J, Spedding M, Antoni FA. Gacsályi I, et al. Among authors: gigler g. Neuropharmacology. 2013 Jan;64:254-63. doi: 10.1016/j.neuropharm.2012.07.017. Epub 2012 Jul 21. Neuropharmacology. 2013. PMID: 22824189
Behavioural pharmacology of the α5-GABAA receptor antagonist S44819: Enhancement and remediation of cognitive performance in preclinical models.
Gacsályi I, Móricz K, Gigler G, Wellmann J, Nagy K, Ling I, Barkóczy J, Haller J, Lambert JJ, Szénási G, Spedding M, Antoni FA. Gacsályi I, et al. Among authors: gigler g. Neuropharmacology. 2017 Oct;125:30-38. doi: 10.1016/j.neuropharm.2017.07.005. Epub 2017 Jul 8. Neuropharmacology. 2017. PMID: 28694097
25 results